Viemed Healthcare, Inc.

Symbol: VMD

NASDAQ

9.38

USD

Market price today

  • 26.7260

    P/E Ratio

  • 0.0462

    PEG Ratio

  • 361.03M

    MRK Cap

  • 0.00%

    DIV Yield

Viemed Healthcare, Inc. (VMD) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.61%

Operating Profit Margin

0.08%

Net Profit Margin

0.05%

Return on Assets

0.09%

Return on Equity

0.09%

Return on Capital Employed

0.18%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Devices
CEO:Mr. Casey Hoyt
Full-time employees:996
City:Lafayette
Address:625 East Kaliste Saloom Road
IPO:2019-08-09
CIK:0001729149

Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

General Outlook

When we look at how much money they make before expenses, they keep 0.609% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.077%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.053%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.089% return, is a testament to Viemed Healthcare, Inc.'s adeptness in optimizing resource deployment. Viemed Healthcare, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.093%. Furthermore, the proficiency of Viemed Healthcare, Inc. in capital utilization is underscored by a remarkable 0.175% return on capital employed.

Stock Prices

Viemed Healthcare, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $8.5, while its low point bottomed out at $8.17. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Viemed Healthcare, Inc.'s stock market.

Liquidity Ratios

Analyzing VMD liquidity ratios reveals its financial health of the firm. The current ratio of 128.23% gauges short-term asset coverage for liabilities. The quick ratio (105.54%) assesses immediate liquidity, while the cash ratio (24.27%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio128.23%
Quick Ratio105.54%
Cash Ratio24.27%

Profitability Ratios

VMD profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 7.49% underscores its earnings before tax deductions. The effective tax rate stands at 28.76%, revealing its tax efficiency. The net income per EBT, 70.58%, and the EBT per EBIT, 96.99%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 7.72%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin7.49%
Effective Tax Rate28.76%
Net Income per EBT70.58%
EBT per EBIT96.99%
EBIT per Revenue7.72%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.28, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding106
Days of Inventory Outstanding21
Operating Cycle66.48
Days of Payables Outstanding13
Cash Conversion Cycle54
Receivables Turnover7.98
Payables Turnover28.57
Inventory Turnover17.57
Fixed Asset Turnover2.55
Asset Turnover1.68

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.95, and free cash flow per share, 0.23, depict cash generation on a per-share basis. The cash per share value, 0.19, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.19, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share0.95
Free Cash Flow per Share0.23
Cash per Share0.19
Operating Cash Flow Sales Ratio0.19
Free Cash Flow to Operating Cash Flow Ratio0.24
Cash Flow Coverage Ratio3.86
Short Term Coverage Ratio24.62
Capital Expenditure Coverage Ratio1.32
Dividend Paid and Capex Coverage Ratio1.32

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 8.20%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.08, we discern the balance between debt and equity financing. The long-term debt to capitalization, 6.47%, and total debt to capitalization, 7.58%, ratios shed light on its capital structure. An interest coverage of 22.52 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio8.20%
Debt Equity Ratio0.08
Long Term Debt to Capitalization6.47%
Total Debt to Capitalization7.58%
Interest Coverage22.52
Cash Flow to Debt Ratio3.86
Company Equity Multiplier1.00

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 4.86, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.27, reflects the portion of profit attributed to each share. The book value per share, 2.95, represents the net asset value distributed per share, while the tangible book value per share, 2.17, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share4.86
Net Income Per Share0.27
Book Value Per Share2.95
Tangible Book Value Per Share2.17
Shareholders Equity Per Share2.95
Interest Debt Per Share0.22
Capex Per Share-0.69

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 34.24%, indicates top-line expansion, while the gross profit growth, 33.96%, reveals profitability trends. EBIT growth, 91.44%, and operating income growth, 91.44%, offer insights into operational profitability progression. The net income growth, 64.63%, showcases bottom-line expansion, and the EPS growth, 80.00%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth34.24%
Gross Profit Growth33.96%
EBIT Growth91.44%
Operating Income Growth91.44%
Net Income Growth64.63%
EPS Growth80.00%
EPS Diluted Growth73.33%
Weighted Average Shares Growth-0.78%
Weighted Average Shares Diluted Growth1.44%
Operating Cash Flow Growth65.93%
Free Cash Flow Growth301.44%
10-Year Revenue Growth per Share487.46%
5-Year Revenue Growth per Share182.08%
3-Year Revenue Growth per Share43.37%
10-Year Operating CF Growth per Share609.50%
5-Year Operating CF Growth per Share103.36%
3-Year Operating CF Growth per Share32.47%
10-Year Net Income Growth per Share724.45%
5-Year Net Income Growth per Share-0.56%
3-Year Net Income Growth per Share-67.18%
10-Year Shareholders Equity Growth per Share769.56%
5-Year Shareholders Equity Growth per Share219.55%
3-Year Shareholders Equity Growth per Share40.11%
Receivables Growth19.16%
Inventory Growth28.83%
Asset Growth31.66%
Book Value per Share Growth17.62%
Debt Growth1380.00%
R&D Expense Growth5.08%
SGA Expenses Growth29.36%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 298,577,325.35, captures the company's total value, considering both debt and equity. Income quality, 4.41, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.50, gauges operational efficiency, while the research and development to revenue, 1.52%, highlights investment in innovation. The ratio of intangibles to total assets, 19.68%, indicates the value of non-physical assets, and capex to operating cash flow, -57.71%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value298,577,325.35
Income Quality4.41
Sales General and Administrative to Revenue0.50
Research and Development to Revenue1.52%
Intangibles to Total Assets19.68%
Capex to Operating Cash Flow-57.71%
Capex to Revenue-14.26%
Capex to Depreciation-119.20%
Stock-Based Compensation to Revenue3.14%
Graham Number4.21
Return on Tangible Assets8.28%
Graham Net Net-0.31
Working Capital6,211,059
Tangible Asset Value82,980,279
Net Current Asset Value-2,619,529
Average Receivables16,880,799.5
Average Payables3,404,306.5
Average Inventory4,089,160.5
Days Sales Outstanding36
Days Payables Outstanding21
Days of Inventory On Hand23
ROIC9.27%
ROE0.09%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 2.37, and the price to book ratio, 2.37, reflect the market's valuation relative to the company's book value. The price to sales ratio, 1.42, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 31.32, and price to operating cash flows, 7.51, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio2.37
Price to Book Ratio2.37
Price to Sales Ratio1.42
Price Cash Flow Ratio7.51
Price Earnings to Growth Ratio0.05
Enterprise Value Multiple8.16
Price Fair Value2.37
Price to Operating Cash Flow Ratio7.51
Price to Free Cash Flows Ratio31.32
Price to Tangible Book Ratio2.66
Enterprise Value to Sales1.60
Enterprise Value Over EBITDA7.84
EV to Operating Cash Flow6.49
Earnings Yield3.40%
Free Cash Flow Yield6.47%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Viemed Healthcare, Inc. (VMD) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 26.726 in 2024.

What is the ticker symbol of Viemed Healthcare, Inc. stock?

The ticker symbol of Viemed Healthcare, Inc. stock is VMD.

What is company IPO date?

IPO date of Viemed Healthcare, Inc. is 2019-08-09.

What is company current share price?

Current share price is 9.380 USD.

What is stock market cap today?

The market cap of stock today is 361026820.000.

What is PEG ratio in 2024?

The current 0.046 is 0.046 in 2024.

What is the number of employees in 2024?

In 2024 the company has 996.